Levobetaxolol

CHEMBL1201274 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
307.4 g/mol
LogP
2.8
Phase
4

This beta-blocker eye drop is used to lower elevated pressure inside the eye in patients with open-angle glaucoma or ocular hypertension. It works by reducing the amount of fluid produced inside the eye, helping to prevent the optic nerve damage that can lead to vision loss.

Molekularmasse

307,4000 g/mol

LogP

2,80

TPSA

50,70 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1

InChI

InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3/t17-/m0/s1

Molecular Formula

C18H29NO3

HBD / HBA

2 / 4

Rotierbare Bindungen

11

Schwere Atome

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This beta-blocker eye drop is used to lower elevated pressure inside the eye in patients with open-angle glaucoma or ocular hypertension. It works by reducing the amount of fluid produced inside the eye, helping to prevent the optic nerve damage that can lead to vision loss.

Yes, Levobetaxolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201274. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 60657. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.